E-LIB Suche - Ergebnisse für: Boge, Lukas

1

Peptide-Loaded Cubosomes Functioning as an Antimicrobial Un..:

Boge, Lukas ; Browning, Kathryn L. ; Nordström, Randi...
ACS Applied Materials & Interfaces. 11 (2019) 24 - p. 21314-21322 , 2019

Link: https://doi.org/10.1021/..

2

Characterization of the in vitro, ex vivo, and in vivo Effi..:

Håkansson, Joakim ; Ringstad, Lovisa ; Umerska, Anita...
Frontiers in Cellular and Infection Microbiology. 9 (2019) - p. , 2019

Link: https://doi.org/10.3389/..

3

Biocompatibility of glycerol monooleate nanoparticles as te..:

Simoni, Edi ; Valente, Filippo ; Boge, Lukas...
International Journal of Pharmaceutics. 572 (2019) - p. 118788 , 2019

Link: https://doi.org/10.1016/..

4

Cubosomes for topical delivery of the antimicrobial peptide..:

Boge, Lukas ; Hallstensson, Karin ; Ringstad, Lovisa...
European Journal of Pharmaceutics and Biopharmaceutics. 134 (2019) - p. 60-67 , 2019

Link: https://doi.org/10.1016/..

5

Freeze-dried and re-hydrated liquid crystalline nanoparticl..:

Boge, Lukas ; Västberg, Amanda ; Umerska, Anita...
Journal of Colloid and Interface Science. 522 (2018) - p. 126-135 , 2018

Link: https://doi.org/10.1016/..

6

Evaluation of toxicity of glycerol monooleate nanoparticles..:

Valente, Filippo ; Bysell, Helena ; Simoni, Edi...
International Journal of Pharmaceutics. 539 (2018) 1-2 - p. 23-30 , 2018

Link: https://doi.org/10.1016/..

7

Cubosomes post-loaded with antimicrobial peptides: characte..:

Boge, Lukas ; Umerska, Anita ; Matougui, Nada...
International Journal of Pharmaceutics. 526 (2017) 1-2 - p. 400-412 , 2017

Link: https://doi.org/10.1016/..

8

Lipid-based nanoformulations for peptide delivery:

Matougui, Nada ; Boge, Lukas ; Groo, Anne-Claire...
International Journal of Pharmaceutics. 502 (2016) 1-2 - p. 80-97 , 2016

Link: https://doi.org/10.1016/..

9

Lipid-Based Liquid Crystals As Carriers for Antimicrobial P..:

Boge, Lukas ; Bysell, Helena ; Ringstad, Lovisa...
Langmuir. 32 (2016) 17 - p. 4217-4228 , 2016

Link: https://doi.org/10.1021/..

10

Characterization of the in vitro, ex vivo, and in vivo Effi..:

Håkansson, Joakim ; Ringstad, Lovisa ; Umerska, Anita...
Frontiers in Cellular and Infection Microbiology, 2019, 9,. , 2019

Link: http://urn.kb.se/resolve..

11

Characterization of the , and Efficacy of the Antimicrobial..:

Håkansson, Joakim ; Ringstad, Lovisa ; Umerska, Anita-Monika...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fcimb.2019.00174. , 2019

Link: https://hal.univ-angers...

12

Characterization of the , and Efficacy of the Antimicrobial..:

Håkansson, Joakim ; Ringstad, Lovisa ; Umerska, Anita-Monika...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fcimb.2019.00174. , 2019

Link: https://univ-angers.hal...

13

Characterization of the in vitro, ex vivo, and in vivo Effi..:

Hakansson, Joakim ; Ringstad, Lovisa ; Umerska, Anita...
https://research.rug.nl/en/publications/e86fdac3-22cb-4e2d-83cf-e2037fa13723. , 2019

Link: https://hdl.handle.net/1..

14

Characterization of the , and Efficacy of the Antimicrobial..:

Håkansson, Joakim ; Ringstad, Lovisa ; Umerska, Anita-Monika...
info:eu-repo/semantics/altIdentifier/doi/10.3389/fcimb.2019.00174. , 2019

Link: https://univ-angers.hal...

15

Characterization of the in vitro, ex vivo, and in vivo Effi..:

Håkansson, Joakim ; Ringstad, Lovisa ; Umerska, Anita...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548878/. , 2019

Link: http://www.ncbi.nlm.nih...